Infectious Disease Alert
RSSArticles
-
Antibacterial Prophylaxis for Patients with Cancer: Should We Use It or Not?
The Ginema study reported by Bucaneve and colleagues recruited for a formal, double-blind, randomized placebo controlled trial of 500 mg/d levofloxacin among 760 patients who were admitted to the hospital and who were at risk of developing neutropenia resulting from treatment of acute leukemia lymphoma or solid tumors. -
Giardiasis and the Risks of Visiting Grandma
Giardiasis, caused by the waterborne protozoan parasite Giardia lamblia, also known as G. intestinalis, and G. duodenalis, is a common cause of diarrhea worldwide. -
Clinical Briefs in Primary Care supplement
-
Clinical Briefs in Primary Care Supplement
-
Updates: Meningitis and Cochlear Implants; Monkeypox Genome: A Surprise Inside; "Polioman" Discovered in Europe
-
Pharmacology Watch: No Shortage in Sight for Tetanus-Diphtheria Vaccine
-
Clinical Briefs in Primary Care Supplement
-
Updates: Diagnosing TB; VRSA Debuts in Michigan
-
Pharmacology Watch: Study Concludes Premarketing Drug Trials Underpowered
-
Antibiotics in Acute Exacerbations of Chronic Bronchitis